Загрузка...
The off-label use of anakinra in pediatric systemic autoinflammatory diseases
Interleukin 1 (IL-1), a central mediator of innate immunity, is considered a master cytokine of local and systemic inflammation. IL-1 has emerged as pivotal in the pathogenesis of autoinflammatory diseases (AIDs), and blockade of its pathway has become a crucial target for therapy. Anakinra (ANA), a...
Сохранить в:
| Опубликовано в: : | Ther Adv Musculoskelet Dis |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
SAGE Publications
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7580132/ https://ncbi.nlm.nih.gov/pubmed/33149772 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1759720X20959575 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|